Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Prostate Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

February 2010
1. COHEN KH , Teh BS, Paulino AC, Butler EB, et al
   Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy.
   Am J Clin Oncol. 2010;33:108.
   PubMed     Text format     Related articles   
   
   
   
2. LIPTON A , Campbell-Baird C, Harvey H, Kim C, et al
   Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases.
   Am J Clin Oncol. 2010;33:75-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. XU N , Rossi PJ, Jani AB
   Toxicity Analysis of Dose Escalation From 75.6 Gy to 81.0 Gy in Prostate Cancer.
   Am J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. TOWNSEND NC , Huth BJ, Ding W, Garber B, et al
   Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer.
   Am J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. TERAKEDIS BE , Rossi PJ, Liauw SL, Johnstone PA, et al
   A Surveillance, Epidemiology, and End Results Registry Analysis of Prostate Cancer Modality Time Trends by Age.
   Am J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
6. SRIDHAR SS , Hotte SJ, Chin JL, Hudes GR, et al
   A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer.
   Am J Clin Oncol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
7. MARTINEZ AA , Demanes J, Vargas C, Schour L, et al
   High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer.
   Am J Clin Oncol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. ZELIADT SB , Ramsey SD, Van Den Eeden SK, Hamilton AS, et al
   Patient Recruitment Methods to Evaluate Treatment Decision Making for Localized Prostate Cancer.
   Am J Clin Oncol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. MENDENHALL WM , Nichols RC, Henderson R, Mendenhall NP, et al
   Is Radical Prostatectomy the "Gold Standard" for Localized Prostate Cancer?
   Am J Clin Oncol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
10. JANI AB , Johnstone PA, Liauw SL, Master VA, et al
    Prostate Cancer Modality Time Trend Analyses From 1973 to 2004: A Surveillance, Epidemiology, and End Results Registry Analysis.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
11. VARGAS C , Saito AI, Hsi WC, Indelicato D, et al
    Cine-Magnetic Resonance Imaging Assessment of Intrafraction Motion for Prostate Cancer Patients Supine or Prone With and Without a Rectal Balloon.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MENDENHALL WM , Henderson RH, Indelicato DJ, Keole SR, et al
    Erectile dysfunction after radiotherapy for prostate cancer.
    Am J Clin Oncol. 2009;32:443-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
13. MENDENHALL WM , Henderson RH, Nichols RC, Keole SR, et al
    Postprostatectomy Radiotherapy for Prostate Cancer.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ECKMAN MH , Ying J, Hertzfeld K, Kumar N, et al
    Longitudinal Analysis of Genitourinary and Bowel Symptoms in Prostate Cancer Patients Following Brachytherapy.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
15. SHAH AP , Chen SS, Strauss JB, Kirk MC, et al
    A Dosimetric Analysis Comparing Treatment of Low-Risk Prostate Cancer With TomoTherapy Versus Static Field Intensity Modulated Radiation Therapy.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
16. DEMANES DJ , Brandt D, Schour L, Hill DR, et al
    Excellent Results From High Dose Rate Brachytherapy and External Beam for Prostate Cancer are Not Improved by Androgen Deprivation.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. PEZARO C , Rosenthal MA, Gurney H, Davis ID, et al
    An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. ARONOWITZ JN
    "Benign essential" prostate cancer?
    Am J Clin Oncol. 2009;32:224-5.
    PubMed     Text format     Related articles   
    
    
    March 2009
19. VARGAS C , Falchook A, Indelicato D, Yeung A, et al
    Proton Therapy for Prostate Cancer Treatment Employing Online Image Guidance and an Action Level Threshold.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. VIANI GA , Pellizzon AC, Guimaraes FS, Jacinto AA, et al
    High Dose Rate and External Beam Radiotherapy in Locally Advanced Prostate Cancer.
    Am J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
21. JANET NL , May AW, Akins RS
    Sarcoma of the prostate: a single institutional review.
    Am J Clin Oncol. 2009;32:27-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
22. MERRICK GS , Wallner KE, Galbreath RW, Butler WM, et al
    Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer.
    Am J Clin Oncol. 2008;31:539-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. AMATO RJ , Hernandez-McClain J, Henary H
    Bone-Targeted Therapy: Phase II Study of Strontium-89 in Combination With Alternating Weekly Chemohormonal Therapies for Patients With Advanced Androgen-Independent Prostate Cancer.
    Am J Clin Oncol. 2008;31:532-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. ORIO PF 3RD , Merrick GS, Grimm P, Blasko J, et al
    Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura database.
    Am J Clin Oncol. 2008;31:523-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
25. MENDENHALL WM , Henderson RH, Mendenhall NP
    Definitive radiotherapy for prostate cancer.
    Am J Clin Oncol. 2008;31:496-503.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
26. NAVARRO M , Ocana A, Alana M, Blanco O, et al
    Third nerve palsy as the initial presenting sign of metastatic prostate cancer.
    Am J Clin Oncol. 2008;31:407-8.
    PubMed     Text format     Related articles   
    
    
    
27. JANI AB , Johnstone PA, Liauw SL, Master VA, et al
    Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
    Am J Clin Oncol. 2008;31:375-8.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: